Preventing cholera outbreaks through early targeted interventions
In a Perspective, Lorenz von Seidlein and Jacqueline L. Deen discuss the implications of Andrew Azman and colleagues' accompanying study for management of cholera outbreaks.
Vyšlo v časopise:
Preventing cholera outbreaks through early targeted interventions. PLoS Med 15(2): e32767. doi:10.1371/journal.pmed.1002510
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002510
Souhrn
In a Perspective, Lorenz von Seidlein and Jacqueline L. Deen discuss the implications of Andrew Azman and colleagues' accompanying study for management of cholera outbreaks.
Zdroje
1. Svennerholm AM, Jertborn M, Gothefors L, Karim A, Sack DA, Holmgren J. Current status of an oral B subunit whole cell cholera vaccine. Dev Biol Stand. 1983;53:73–9. Epub 1983/01/01. 6873479.
2. WHO. Prequalification of medicines by WHO. 2017. Available from: http://www.who.int/mediacentre/factsheets/fs278/en/.
3. Lopez AL, Gonzales ML, Aldaba JG, Nair GB. Killed oral cholera vaccines: history, development and implementation challenges. Ther Adv Vaccines. 2014;2(5):123–36. Epub 2014/09/02. doi: 10.1177/2051013614537819 25177492; PubMed Central PMCID: PMC4144262.
4. WHO. Meeting of the Strategic Advisory Group of Experts on immunization, October 2009—conclusions and recommendations. Wkly Epidemiol Rec. 2009;50:526–8.
5. Date KA, Vicari A, Hyde TB, Mintz E, Danovaro-Holliday MC, Henry A, et al. Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010–2011. Emerg Infect Dis. 2011;17(11):2105–12. Epub 2011/11/22. doi: 10.3201/eid1711.110822 22099114; PubMed Central PMCID: PMC3310586.
6. von Seidlein L, Deen JL. Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010–2011. Emerg Infect Dis. 2012;18(7):1211–4. Epub 2012/06/20. doi: 10.3201/eid1807.120071 22709425; PubMed Central PMCID: PMC3376809.
7. Ivers LC, Teng JE, Lascher J, Raymond M, Weigel J, Victor N, et al. Use of oral cholera vaccine in Haiti: a rural demonstration project. Am J Trop Med Hyg. 2013;89(4):617–24. Epub 2013/10/10. doi: 10.4269/ajtmh.13-0183 24106187; PubMed Central PMCID: PMC3795090.
8. Ivers LC, Farmer PE, Pape WJ. Oral cholera vaccine and integrated cholera control in Haiti. Lancet. 2012;379(9831):2026–8. Epub 2012/06/05. doi: 10.1016/S0140-6736(12)60832-0 22656874.
9. Finger F, Bertuzzo E, Luquero FJ, Naibei N, Toure B, Allan M, et al. The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study. PLoS Med. 2018;15(2): e1002509. doi: 10.1371/journal.pmed.1002509
10. Pezzoli L (on behalf of the Oral Cholera Vaccine Working Group of the Global Task Force on Cholera Control). Deployments from the oral cholera vaccine stockpile, 2013–2017. Wkly Epidemiol Rec. 2017;92(32):437–42. Epub 2017/08/12. 28799734.
11. AMP. GAVI Alliance Approved a Contribution Towards a Global Cholera Vaccine Stockpile for the period 2014–2018. 2013. Available from: http://amp-vaccinology.org/fr/news-article/2013-22-11/gavi-alliance-approved-contribution-towards-global-cholera-vaccine-stockpile
12. Desai SN, Pezzoli L, Martin S, Costa A, Rodriguez C, Legros D, et al. A second affordable oral cholera vaccine: implications for the global vaccine stockpile. Lancet Glob Health. 2016;4(4):e223–4. Epub 2016/03/26. doi: 10.1016/S2214-109X(16)00037-1 27013303.
13. Global Task Force On Cholera Control. Ending Cholera—A Global Roadmap To 2030. 2017. Available from: http://www.who.int/cholera/publications/global-roadmap.pdf
14. UNICEF. World’s second largest oral cholera vaccination campaign kicks off at Rohingya camps in Bangladesh. 2017. Available from: https://www.unicef.org/media/media_101045.html
15. WHO. Yemen Cholera Response Weekly Epidemiological Bulletin W50 2017 (Dec 11–Dec 17). 2017. Available from: http://www.emro.who.int/images/stories/yemen/Yemen_Cholera_Response_-_Weekly_Epidemiological_Bulletin_-_W50_2017_Dec_11-Dec_17.pdf
16. Waldman M. Cholera vaccination campaign in Yemen is dropped. Science. 2017. Available from: http://www.sciencemag.org/news/2017/07/cholera-vaccination-campaign-yemen-dropped
17. WHO. International Coordinating Group (ICG) on vaccine provision for cholera. 2016. Available from: http://www.who.int/csr/disease/icg/cholera/en/
18. WHO. The Global Task Force on Cholera Control. 2017. Available from: http://www.who.int/cholera/introduction/en/
19. Anh DD, Lopez AL, Tran HT, Cuong NV, Thiem VD, Ali M, et al. Oral cholera vaccine development and use in Vietnam. PLoS Med. 2014;11(9):e1001712. Epub 2014/09/03. doi: 10.1371/journal.pmed.1001712 25180511; PubMed Central PMCID: PMC4151976.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2018 Číslo 2
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study
- Susceptibility of to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016
- Prevalence of sexually transmitted infections among young people in South Africa: A nested survey in a health and demographic surveillance site
- Diet during pregnancy and infancy and risk of allergic or autoimmune disease: A systematic review and meta-analysis